West Pharmaceutical Services Inc (WST) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
West Pharmaceutical Services Inc   (NYSE: WST)


West Pharmaceutical Services Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is West Pharmaceutical Services Inc's ROI in the second quarter of 2026?
West Pharmaceutical Services Inc achieved a return on average invested assets (ROI) of 15.75 % in its second quarter of 2026, this is above WST's average return on investment of 13.76%.
West Pharmaceutical Services Inc s investments during the 12 months ending in the second quarter of 2026 are valued at $3 billion

ROI has improved compared to 15.11% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 54 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 501 to 503.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 12.91 % 19.77 % 20.09 % 12.7 % 7.63 %
Y / Y Net Income Change TTM 15.83 % 16.16 % 30.82 % 98.83 % 338.19 %
Investment (TTM) in Millions 3,436 3,530 3,774 3,604 3,463
Return On Investment (TTM) 15.75 % 15.11 % 14.08 % 14.86 % 15.36 %
WST's Overall Ranking # 503 # 501 # 456 # 46 # 285
Seq. Investment Change TTM -0.19 % 2.49 % 5.9 % 4.23 % 5.88 %
Seq. Net Income Change TTM 4.09 % 9.93 % 0.41 % 0.82 % 4.39 %
Net Income (TTM) in Millions 565 543 494 492 488

WST Company Profile >> Back to WST Roi Comparisons >> See Annual WST Return On Investment



Return On Investment WST's Ranking
Within: No.
Industry # 12
Sector # 55
Overall # 503

Return On Investment Statistics
High Average Low
26.42 %
13.76 %
5.54 %
(Dec 31 2021)   (Sep 30 2011)







Financial Statements
West Pharmaceutical Services Inc's II. Quarter Investments $ 3,436 Millions WST's Balance sheet
West Pharmaceutical Services Inc's II. Quarter Income $ 154 Millions Quarterly WST's Income Statement
WST's Income by Division See WST's Income by Division


WST Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 3,497 2,991 3,061 2,991 2,652
Y / Y Investment Growth 16.91 % -2.28 % 2.34 % 12.77 % 19.47 %
Net Income in Millions 494 493 593 586 662
Y / Y Net Income Growth 0.2 % -16.97 % 1.28 % -11.47 % 91.16 %
Annual Return On Investment 14.12 % 16.47 % 19.39 % 19.59 % 24.96 %


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 14.12 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
WST's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for WST's Competitors
Subscribers only: Roi for West Pharmaceutical Services Inc's Suppliers
Subscribers only: Return On Investment for WST's Customers

Other Ratios
WST's Roa WST's Inventory Turnover Ratio WST's Growth Rates WST's Dividend Statistics
WST's Profitability Ratios WST's Asset Turnover Ratio WST's Dividend Growth
WST's Roe WST's Valuation Ratios WST's Financial Strength Ratios WST's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Liquidia Corporation  42.09 %
Tg Therapeutics Inc   39.26 %
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %

Date modified: 2026-09-26T07:18:32+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.